Xinfan Li

Company: Mabplex
Job title: Chief Operating Officer
Bio:
- D. in Molecular Biology and Biochemistry from Peking University in Beijing China
- Post-Doctorate at Harvard University
- Her work has directly impacted more than 20 product approvals by the FDA
- Holds multiple patents and publications in Antibody Drug Conjugate preparation and purification technologies
- She is an expert in viral clearance
Seminars:
Key CMC Considerations for Integrated ADC Development to Production 11:40 am
Integrated conjugate development approach at Mabplex including early stage linker-toxin combination evaluation Implementation of new technology or continuous improvement Time line fits customer needs based on risk assessmentRead more
day: Day One